Table 1

Baseline Demographic Characteristics of the Patients

IVUS PopulationIVUS Versus Non-IVUS Population
Everolimus 1.5 mg
(n = 88)
MMF 3 g
(n = 101)
p ValueTotal IVUS
(n = 189)
Total Non-IVUS
(n = 364)
p Value
Age, yrs51.1 ± 11.849.5 ± 13.10.56450.3 ± 12.550.9 ± 10.90.983
Male70 (79.5)88 (87.1)0.173158 (83.6)287 (78.8)0.213
Caucasian61 (69.3)78 (77.2)0.249139 (73.5)312 (85.7)<0.001
Weight, kg76.5 ± 17.177.2 ± 15.10.61976.9 ± 16.078.1 ± 16.10.437
Height, cm171.6 ± 9.0173.3 ± 9.40.168172.5 ± 9.2173.3 ± 9.60.322
BMI, kg/m225.8 ± 4.425.6 ± 4.00.76425.7 ± 4.225.8 ± 4.60.935
Primary reason for heart transplantation
 Idiopathic cardiomyopathy29 (33.0)38 (37.6)0.54467 (35.4)161 (44.2)0.045
 Coronary artery disease14 (15.9)21 (20.8)0.45435 (18.5)78 (21.4)0.438
 Other45 (51.1)42 (42.6)0.24187 (46.0)122 (33.5)0.005
Recipient negative for CMV, donor positive16 (18.2)23 (22.8)0.47539 (20.6)70 (19.2)0.735
Induction therapy65 (73.9)80 (79.2)0.394145 (76.7)222 (61.0)<0.001
Age of donor, yrs36.0 ± 13.234.1 ± 13.10.27835.0 ± 13.134.2 ± 13.10.556
Mean duration of cold ischemia, h3.3 ± 1.03.4 ± 1.10.9573.2 ± 1.13.1 ± 1.10.177
Baseline creatinine, mg/dl1.32 ± 0.621.33 ± 0.490.5341.33 ± 0.551.42 ± 0.620.129

Values are mean ± SD or n (%).

Bold values indicate p<0.05.

BMI = body mass index; CMV = cytomegalovirus; IVUS, intravascular ultrasound; IVUS = intravascular ultrasound; MMF = mycophenolate mofetil.